Interaction of catechol-O-methyltransferase (COMT) Val108/158 Met genotype and risperidone treatment in Chinese Han patients with schizophrenia

Psychiatry Research

Volumn 176, Issue 1, 2010, Pages 94-95

  Kang, Chuan Yuan ^a   Xu, Xiu Feng ^a   Liu, Hua ^a   Shi, Zhen Yu ^a   Xu, Hong Hui ^a   Yang, Jian Zhong ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; RISPERIDONE; VALINE;

AMINO ACID SUBSTITUTION; CHINESE; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PHARMACOGENETICS; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CATECHOL O-METHYLTRANSFERASE; FOLLOW-UP STUDIES; HUMANS; METHIONINE; PHARMACOGENETICS; RISPERIDONE; SCHIZOPHRENIA; VALINE;

EID: 76549096827     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.02.009     Document Type: Letter

References (19)

1. Bertolino A., Caforio G., Blasi G., De Candia M., Latorre V., Petruzzella V., Altamura M., Nappi G., Papa S., Callicott J.H., Mattay V.S., Bellomo A., Scarabino T., Weinberger D.R., and Nardini M. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. American Journal of Psychiatry 161 (2004) 1798-1805
2. Bertolino A., Caforio G., Blasi G., Rampino A., Nardini M., Weinberger D.R., Dallapiccola B., Sinibaldi L., and Douzgou S. COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia. Schizophrenia Research 95 (2007) 253-255
3. Carlsson A. The neurochemical circuitry of schizophrenia. Pharmacopsychiatry 39 (2006) S10-S14
4. Chen C.H., Lee Y.R., Chung M.Y., Wei F.C., Koong F.J., Shaw C.K., Yeh J.I., and Hsiao K.J. Systematic mutation analysis of the catechol O-methyltransferase gene as a candidate gene for schizophrenia. American Journal of Psychiatry 156 (1999) 1273-1275
5. Daniels J.K., Williams N.M., Williams J., Jones L.A., Cardno A.G., Murphy K.C., Spurlock G., Riley B., Scambler P., Asherson P., McGuffin P., and Owen M.J. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. American Journal of Psychiatry 153 (1996) 268-270
6. Deutch A.Y. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. Journal of Neural Transmission Supplement 36 (1992) 61-89
7. Fan J.B., Chen W.Y., Tang J.X., Li S., Gu N.F., Feng G.Y., Breen G., Clair St., and He L. Family-based association studies of COMT gene polymorphisms and schizophrenia in the Chinese population. Molecular Psychiatry 7 (2002) 446-447
8. Galderisi S., Maj M., Kirkpatrick B., Piccardi P., Mucci A., Invernizzi G., Rossi A., Pini S., Vita A., Cassano P., Stratta P., Severino G., and Del Z.M. COMT Val (158) Met and BDNF C (270) T polymorphisms in schizophrenia: a case-control study. Schizophrenia Research 73 (2005) 27-30
9. Goldberg T.E., Egan M.F., Gscheidle T., Coppola R., Weickert T., Kolachana B.S., Goldman D., and Weinberger D.R. Executive subprocesses in working memory: relationship to catechol-O-ethyltransferase Val158Met genotype and schizophrenia. Archive of General Psychiatry 60 (2003) 889-896
10. Hagen K., Stovner L.J., Skorpen F., Pettersen E., and Zwart J.A. COMT genotypes and use of antipsychotic medication: linking population-based prescription database to the HUNT study. Pharmacoepidemiology and Drug Safety 17 (2008) 372-327
11. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 10 (2005) 40-68
12. Ho B.C., Wassink T.H., O'Leary D.S., Sheffield V.C., and Andreasen N.C. Catechol-O-methyl transferase Val (158)Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Molecular Psychiatry 10 (2005) 287-298
13. Illi A., Mattila K.M., Kampman O., Anttila S., Roivas M., Lehtimäki T., and Leinonen E. Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia. Journal of Clinical Psychopharmacology 23 (2003) 429-434
14. Inada T., Nakamura A., and Iijima Y. Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 120 (2003) 35-39
15. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., and Weinshiloum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 (1996) 243-250
16. Molero P., Ortuno F., Zalacain M., and Patino-Garcia A. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment. The Pharmacogenomics Journal 7 (2007) 418-426
17. Stefanis N.C., Van Os. J., Avramopoulos D., Smyrnis N., Evdokimidis I., Hantoumi I., and Stefanis C.N. Variation in catechol-O-methyltransferase val158 met genotype associated with schizotypy but not cognition: a population study in 543 young men. Biological Psychiatry 56 (2004) 510-515
18. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry 44 (1987) 660-669
19. Yu R., Zhang X.N., Huang X.X., Ding S.P., and Li J.C. Association analysis of COMT polymorphisms and schizophrenia in a Chinese Han population: a case-control study. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 144 (2007) 570-573